Reporting suspected adverse reactions after authorisation of the medicinal product is important. Other Adverse Drug Reactions identified in published literature include: General Disorders and Administrative Site ConditionsĪpplication site reactions (including burning sensation, irritation, pruritus and dry scalp) Hypersensitivity (including Urticaria, Photosensitization) This medicine contains fragrance with the following components which may cause allergic reactions: Alpha-Isomethyl-ionone, Amyl Cinnamal, AmylCinnamyl Alcohol, Anise Alcohol, Benzyl Benzoate, Benzyl Cinnamate, Benzyl Salicylate, Butylphenyl Methylpropional, Cinnamal, Cinnamyl Alcohol, Citral, Citronellol, Coumarin, Eugenol, Evernia Furfuracea (Treemoss) Extract, Evernia Prunastri (Oakmoss) Extract, Farnesol, Geraniol, Hexyl Cinnamal, Hydroxycitronellal, Hydroxyisohexyl-3-Cyclohexene Carboxaldehyde, Hydroxyisohexyl 3-&4-Cyclohexene Carboxaldehyde (HMPCC), Isoeugenol, Limonene, Linalool and Methyl-2-Octynoate.
Nutragina tcel skin#
In rare instances, temporary discoloration of grey, blonde, bleached or tinted hair may occur.Ĭoal tar may have a photosensitising action and caution should be exercised in exposing skin to sunlight after use.Ĭontains Methyl (E218) and Propyl (E216) parahydroxybenzoates which may cause allergic reactions (possibly delayed).Įsters of benzoic acid, benzyl benzoate and butylated hydroxytoluene (E321) may cause local skin reactions (e.g contact dermatitis), or irritation to the eyes and mucous membranes. If contact occurs, rinse eyes thoroughly with water. If irritation develops, discontinue use and consult a physician.Ĭontact with eyes should be avoided. Date of first authorisation/renewal of the authorisation
4.7 Effects on ability to drive and use machines.4.5 Interaction with other medicinal products and other forms of interaction.4.4 Special warnings and precautions for use.4.2 Posology and method of administration.Show table of contents Hide table of contents
0 kommentar(er)
